ArticleJournal for immunotherapy of cancer2020

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio.

Erika J Crosby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.